Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neovascular Age-Related Macular Degeneration (nAMD)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT02161575
What this trial is testing

Safety and Efficacy of Switching From Aflibercept to Ranibizumab in Patients With nAMD

Who this might be right for
Neovascular Age-related Macular Degeneration
Novartis Pharmaceuticals 103
Testing effectiveness (Phase 2)Looking for participantsNCT07776522
What this trial is testing

Phase II Study of Subretinal JWK001 for Neovascular Age-Related Macular Degeneration

Who this might be right for
Neovascular Age-Related Macular Degeneration (nAMD) Wet AMD
West China Hospital 50
Large-scale testing (Phase 3)Active Not RecruitingNCT05407636
What this trial is testing

Pivotal 2 Study of RGX-314 Gene Therapy in Participants With nAMD

Who this might be right for
AMDnAMDWet Age-related Macular Degeneration+3 more
AbbVie 735
Early research (Phase 1)Study completedNCT04635800
What this trial is testing

Evaluate the Safety, Tolerability and Pharmacokinetics of IVT MHU650 in Macular Edema Patients

Who this might be right for
Macular EdemaDiabetic Macular EdemaNeovascular Age-related Macular Degeneration+1 more
Novartis Pharmaceuticals 21
Large-scale testing (Phase 3)Looking for participantsNCT07482176
What this trial is testing

Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-related Macular Degeneration (AQUARIUS)

Who this might be right for
Neovascular Age-Related Macular Degeneration (nAMD)Wet AMD
Adverum Biotechnologies, Inc. 284
Not applicableStudy completedNCT03909425
What this trial is testing

Defining Disease Activity in Neovascular AMD With Optical Coherence Tomography Angiography

Who this might be right for
Neovascular Age-related Macular Degeneration
Moorfields Eye Hospital NHS Foundation Trust 35
Early research (Phase 1)Not Yet RecruitingNCT07406438
What this trial is testing

To Evaluate the Safety, Pharmacokinetics, and Efficacy of GB10 Intravitreal Injection in Patients With Neovascular Age-related Macular Degeneration (nAMD)

Who this might be right for
Neovascular Age-Related Macular Degeneration (nAMD)
Shenzhen Kexing Pharmaceutical Co., Ltd. 48
Large-scale testing (Phase 3)Active Not RecruitingNCT06223958
What this trial is testing

Study to Evaluate the Efficacy and Safety of Intravitreal OTX-TKI (Ocular Therapeutix) (Axitinib Implant) in Subjects With Neovascular Age-Related Macular Degeneration

Who this might be right for
Neovascular Age-Related Macular Degeneration
Ocular Therapeutix, Inc. 344
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07178249
What this trial is testing

Evaluating the Safety and Preliminary Efficacy of EXG202 Gene Therapy for Neovascular AMD

Who this might be right for
Wet Age-related Macular Degeneration
Guangzhou Jiayin Biotech Ltd 60
Not applicableStudy completedNCT03411941
What this trial is testing

Evaluate the Effectiveness of Intravitreal (IVT) Aflibercept Injection in Clinical Practice in naïve Patients With Neovascular Age-related Macular Degeneration (nAMD)

Who this might be right for
Macular Degeneration
Bayer 116
Large-scale testing (Phase 3)Study completedNCT04239027
What this trial is testing

Assess the Effects of Brolucizumab in Adult Patients With Neovascular Age Related Macular Degeneration

Who this might be right for
Neovascular Age Related Macular Degeneration
Novartis Pharmaceuticals 210
Not applicableActive Not RecruitingNCT06929143
What this trial is testing

Learn More About the Use of Aflibercept in Routine Medical Practice in Japanese Participants With Neovascular Age-related Macular Degeneration and Diabetic Macular Edema

Who this might be right for
Neovascular Age-related Macular Degeneration (nAMD)Diabetic Macular Edema (DME)
Bayer 3,000
Very early researchLooking for participantsNCT06031727
What this trial is testing

CRISPR/cas13-medIated RNA TarGeting THerapy for the Treatment of Neovascular Age-related Macular Degeneration Investigator-initiated Trial (SIGHT-I)

Who this might be right for
Neovascular Age-related Macular Degeneration(nAMD)
HuidaGene Therapeutics Co., Ltd. 12
Not applicableLooking for participantsNCT07308639
What this trial is testing

DATA-INSIGHT is a Project That Looks at Health Data in Germany to Find Out How Many Patients Suffer From Eye Disease. The Project Also Explores New Ways to Collect and Use Publicly Available Healthcare Information.

Who this might be right for
Neovascular Age-related Macular Degeneration (nAMD), Diabetic Macular Edema (DME), Retinal Vein Occlusion (RVO)
Bayer 50,000
Large-scale testing (Phase 3)Study completedNCT01948830
What this trial is testing

Randomized Study for Efficacy and Safety of Ranibizumab 0.5mg in Treat-extend and Monthly Regimens in Patients With nAMD

Who this might be right for
Age-related Macular DegenerationChoroidal Neovascularization
Novartis Pharmaceuticals 650
Testing effectiveness (Phase 2)Ended earlyNCT04746963
What this trial is testing

Safety and Bioactivity of AXT107 in Subjects With Neovascular Age-Related Macular Degeneration

Who this might be right for
Neovascular Age-Related Macular Degeneration (nAMD)
AsclepiX Therapeutics, Inc. 3
Testing effectiveness (Phase 2)Looking for participantsNCT06672536
What this trial is testing

Multicenter, Phase I/II Study to Evaluate the Safety, Tolerability, PK and Efficacy of SCT520FF in Patients With nAMD

Who this might be right for
nAMD
Sinocelltech Ltd. 82
Post-approval studies (Phase 4)Looking for participantsNCT04853251
What this trial is testing

A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Treated With the Port Delivery System With Ranibizumab (PDS)

Who this might be right for
Neovascular Age-related Macular Degeneration
Genentech, Inc. 188
Not applicableLooking for participantsNCT04985487
What this trial is testing

Regulatory Post-Marketing Surveillance Study for Brolucizumab

Who this might be right for
Neovascular Age-related Macular Degeneration
Novartis Pharmaceuticals 3,000
Testing effectiveness (Phase 2)Study completedNCT04331730
What this trial is testing

Assess the Efficacy and Safety of AKST4290 With Aflibercept in Patients With Newly Diagnosed nAMD

Who this might be right for
Neovascular Age-related Macular Degeneration
Alkahest, Inc. 107
Next Page